期刊文献+

肝硬化腹水患者在肝移植手术中行液体治疗的护理

原文传递
导出
摘要 2006年1月-2007年12月,我科对30例肝硬化腹水患者在肝移植手术中实施精心的液体护理管理,针对液体治疗的重点环节进行护理,效果满意,现报道如下。
作者 张金芝
出处 《中国实用护理杂志》 北大核心 2009年第5期21-22,共2页 Chinese Journal of Practical Nursing
  • 相关文献

参考文献4

  • 1贺爱华.影响无痉挛电休克治疗成败的因素分析[J].临床精神医学杂志,1997,7(1):22-23. 被引量:9
  • 2徐晓光,蔡洪培.肝硬化低钠血症研究进展[J].中华消化杂志,2002,22(9):560-562. 被引量:95
  • 3Huluvath PJ,Morss T,Thompson R.Spontaneous bacterial peritonitisin-hospital mortality,predictors of survival,and health care costs from 1989 to 1998.Am J Gastroenterol,2001,96(4):1232-1236.
  • 4Lodge JP ,Jones RM. Efficacy and safety of repeated perioperative doses of recombinant factor Ⅶa in liver transplantation. Liver Transplant, 2005,11:973-979.

二级参考文献11

  • 1南京医学院,南京医学院第一附属医院.临床药物手册[M]上海科学技术出版社,1986.
  • 2Decaux G.Difference is solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985[].Journal of Laboratory and Clinical Medicine.2001
  • 3Gadano A,Moreau R,Pessione F,et al.Aquaretic effects of niravoline, a kappa-opioid agonist, in patients with cirrhosis[].Journal of Hepatology.2000
  • 4Gines P,Jimenez W.Aquaretic agent: a new potential treatment of dilutional hyponatremia in cirrhosis[].Journal of Hepatology.1996
  • 5Gines P,Jimenez W.Aquaretic agents: a new potential treatment of dilutional hyponatremia in cirrhosis[].Journal of Hepatology.1996
  • 6Bosch-Marce M,Jimenez W,Angeli P,et al.Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention[].Gastroenterology.1995
  • 7Bosch-Marce M,Poo JL,Jimenez W,et al.Comparison of two aquaretic drugs (niravoline and OPC-31260) in cirrhotic rats with ascites and water retention[].Journal of Pharmacology and Experimental Therapeutics.1999
  • 8Borroni G,Maggi A,Sangiovanni A,et al.Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients[].Digestive and Liver Disease.2000
  • 9Serradeil-Le-Gal C.Nonpeptide antagonists for vasopressin receptors.Pharmacology of SR 121463A, a new potent and highly selective V2 receptor antagonist[].Advances in Experimental Medicine and Biology.1998
  • 10Yamamura Y,Ogawa H,Yamashita H,et al.Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist[].British Journal of Pharmacology.1992

共引文献102

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部